Prevalenceof abdominal aortic aneurysm among stage 3-4 chronic kidney disease patients aged 55 years and older

Keywords: chronic kidney disease, abdominal aortic aneurysm, ultrasonography, prevalence.

Abstract

The risk of cardiovascular disease begins to increase from the early stages of chronic kidney disease (CKD). Abdominal aortic aneurysms are the most common arterial aneurysms of peripheral arterial diseases. The frequency of abdominal aortic aneurysm varies according to the population studied. This study aimed to determine the prevalence of abdominal aortic aneurysm in patients with stage 3-4  CKD and investigate  CKD is a risk factor for abdominal aortic aneurysm formation.

Methods. Patients aged 55 years and older who were followed up in the internal medicine outpatient clinics were enrolled. Two hundred CKD patients with glomerular filtration rates between 15-59 mL/min per 1.73 m2 were included in the study group, and 110 patients with glomerular filtration rates of 60 mL/min per 1.73 m2 or above were assigned to the control group. An ultrasonography device with a 3.5 MHz probe was used for screening. Abdominal aortic diameters of 3 cm and above were accepted as abdominal aortic aneurysms.

Results. Eighteen patients in the study group (9%) and four in the control group (3.6%) had an abdominal aortic aneurysm. The prevalence of abdominal aortic aneurysms was higher in the  CKD  group. However, the difference was not statistically significant (p=0.078). Moreover, the median aortic diameter was 21.8 mm (14-44 mm) in the study group, compared to 21.0 mm (14-46 mm) in the control group. The prevalence of the abdominal aortic aneurysm was 14.9% in stage 4  CKD patients and 6% in stage 3  CKD patients (p=0.038).

Conclusion. An abdominal aortic aneurysm is more common in patients with  CKD although it does not reach statistical significance. The median aortic diameter was significantly wider in CKD patients compared to the control group . The prevalence of abdominal aortic aneurysm increased with an increase in the CKD stage .

Downloads

Download data is not yet available.

References

Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998 Dec;9(12):16-23. URL: https://www.ncbi.nlm.nih.gov/pubmed/11443763

Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005 Jun;20(6):1048-56. https://doi.org/10.1093/ndt/gfh813

Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urology and Nephrology. 2004 Sep 1;56(3):279-288. URL: http://europepmc.org/article/med/15467506

Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 Mar 21;113(11):654-63. https://doi.org/10.1161/CIRCULATIONAHA.106.174526

Thompson MW, Sayers RD. Arterial aneurysms. In: Beard JD, Gaines PA, editors. Vascular and Endovascular Surgery. London: WB Saunders Ltd.; 1998. p. 253-85.

Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002 Nov 16;360(9345):1531-9. https://doi.org/10.1016/s0140-6736(02)11522-4

Lawrence OF, Oderich GSC, Bhirangi K. Epidemiology of aortic aneurysmal disease. In: Ballard JL, editor. Aortic Surgery. Georgetown: Landes Bioscience; 2000. p. 9-19.

Van Gils PF, de Wit GA, Schuit AJ, van den Berg M. Screening for AAA effectivity and cost effectiveness. Ned Tijdschr Geneeskd. 2009;153:B383. URL: https://research.vu.nl

U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005 Feb 1;142(3):198-202. https://doi.org/10.7326/0003-4819-142-3-200502010-00011

Gillum RF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol. 1995 Nov;48(11):1289-98. https://doi.org/10.1016/0895-4356(95)00045-3

Cronenwett JL, Krupski WC, Rutherford RB. Abdominal aortic and iliac aneurysms. In: Rutherford RB, Cronenwett JL, Gloviczki P, Johnston KW, Kempczinski RF, Krupski WC, editors. Vascular surgery. 5th ed. Philadelphia: W. B. Saunders Company; 2000. p. 1246-81.

Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005 Feb 1;142(3):203-11. https://doi.org/10.7326/0003-4819-142-3-200502010-00012

Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000 May 22;160(10):1425-30. https://doi.org/10.1001/archinte.160.10.1425

Lederle FA, Johnson GR, Wilson SE. Abdominal aortic aneurysm in women. J Vasc Surg. 2001 Jul;34(1):122-6. https://doi.org/10.1067/mva.2001.115275

Norman PE, Jamrozik K, Lawrence-Brown MM, Dickinson JA. Western Australian randomized controlled trial of screening for abdominal aortic aneurysm. Br J Surg. 2003 April;90(4):491-509. https://doi.org/10.1002/bjs.4108

Kandemir A., Nergizoglu G. Abdominal Aortic Aneurysm Occurrence and Risk Factors In Hemodialysis Patients. Sakarya Medical Journal 2018;8(1):14-19. https://doi.org/10.31832/smj.380824

Adeera L. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003 Mar-Apr;16(2):101-5. https://doi.org/10.1046/j.1525-139x.2003.16025.x

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 Sep 23;351(13):1296-305. https://doi.org/10.1056/NEJMoa041031

Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med. 1997 Mar 15;126(6):441-9. https://doi.org/10.7326/0003-4819-126-6-199703150-00004

Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg. 1995 Aug;82(8):1066-70. https://doi.org/10.1002/bjs.1800820821

Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ, Schurink GW. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003 Mar 4;107(8):1103-5. https://doi.org/10.1161/01.cir.0000059938.95404.92

Domanovits H, Schillinger M, Müllner M, Hölzenbein T, Janata K, Bayegan K, Laggner AN. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis. 2002 Aug;163(2):297-302. https://doi.org/10.1016/s0021-9150(02)00006-0

Vega de Céniga M, Esteban M, Quintana JM, Barba A, Estallo L, de la Fuente N, Viviens B, Martin-Ventura JL. Search for serum biomarkers associated with abdominal aortic aneurysm growth – A pilot study. Eur J Vasc Endovasc Surg. 2009 Mar;37(3):297-9. https://doi.org/10.1016/j.ejvs.2008.11.014

Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):69-74. https://doi.org/10.1097/01.hjr.0000114706.27531.01

Holmes DR, Liao S, Parks WC, Thompson RW. Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysm degeneration with pathophysiological implications. J Vasc Surg. 1995 May;21(5):761-72. https://doi.org/10.1016/s0741-5214(05)80007-2


Abstract views: 983
PDF Downloads: 13314
Published
2020-03-24
How to Cite
Karaarslan Cengiz, O., & Nergizoglu, G. (2020). Prevalenceof abdominal aortic aneurysm among stage 3-4 chronic kidney disease patients aged 55 years and older. Ukrainian Journal of Nephrology and Dialysis, (2(66), 9-16. https://doi.org/10.31450/ukrjnd.2(66).2020.02